home | about us | attorneys | actos | bladder cancer | faqs | articles | law resources | press release | contact us | blog | Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +
Researchers find link between vitamin D and bladder cancer
Posted on November 2nd, 2012
No Comments
Researchers from Spain’s National Cancer Research Center have discovered what they believe to be a relationship between bladder cancer and vitamin D. Their research indicates that high levels of vitamin D can lead to a decreased risk of bladder cancer while a deficiency in the vitamin can actually increase a person’ s risk of the [...]
Takeda warns doctors of Actos’ bladder cancer risk
Posted on April 25th, 2012
No Comments
Takeda Pharmaceutical, the largest drug manufacturer in Asia, has admitted that its flagship Type 2 diabetes drug, Actos, has a risk of causing bladder cancer. Actos and other pioglitazone-containing drugs can have several serious and potentially fatal side effects. The company wrote a letter to doctors warning them of the risks that are associated with [...]
Man seeks damages from Takeda after developing bladder cancer from Actos
Posted on February 9th, 2012
No Comments
A man from Houma has filed a lawsuit claiming that his diabetes medication caused him to develop bladder cancer. The man is now seeking compensation from the drug maker, Takeda Pharmaceuticals after he contracted bladder cancer from the Type II diabetes medication, Actos. The lawsuit stated that the man used Actos for over a year [...]
Low profits cause Takeda to cut back on workforce
Posted on January 18th, 2012
No Comments
Takeda Pharmaceuticals has stated that they will be cutting nine percent of their workforce in order to make up for an 11-year low in profits. The company will be cutting 2,800 jobs over a four year period and this will take place mainly in the U.S. and Europe. The drug maker is hoping that the [...]
Europe drug regulators keep Actos on shelves
Posted on January 12th, 2012
No Comments
The European Commission has announced that Takeda Pharamceutical’s diabetes medication, Actos, can still be prescribed in the country after safety reviews were done. Although the medication will still be able to be prescribed, the warning label on it will be updated with information that the use of the product for long periods of time may [...]
Actos bladder cancer attorneys, Actos bladder cancer lawsuit attorneys, Actos bladder cancer lawsuit lawyers
Actos and bladder cancer lawyers, Actos bladder cancer attorneys, Actos bladder cancer lawsuit
Tagged Actos and bladder cancer lawyers, Actos bladder cancer attorneys, Actos bladder cancer lawsuit
Leave a comment
More Actos lawsuits filed in California
Posted on January 9th, 2012
No Comments
Three California couples have filed lawsuits against Takeda Pharmaceuticals, the makers of the Actos diabetes medication after they claim that the medication caused them to develop bladder cancer when taken for over a year. The lawsuits state that the pharmaceutical company hid this risk from consumers who took the product. Plaintiffs in the lawsuit are [...]
The FDA on Actos
Posted on November 28th, 2011
No Comments
The Food and Drug Administration has been investigating the use of the type 2 diabetes medication, Actos, since September 2010. In June 2011, the FDA announced that medications containing the ingredient pioglitazone( an active ingredient in Actos) must have a warning label on them about extended use of the medication and its link to bladder [...]
Bladder cancer: Statistics and Facts
Posted on November 21st, 2011
No Comments
Bladder cancer can have multiple painful side effects and it can be potentially fatal if not treated in time. There are a few important facts and statistics that are important to note. For example, over 65,000 people a year are diagnosed with this type of cancer. Of these people, men are three times more likely [...]
Actos sales fall after bladder cancer risk reported
Posted on November 7th, 2011
No Comments
The sales of the type 2 diabetes drug, Actos, have decreased after the reports were released that the drug has been linked to the increased risk of bladder cancer when taken for over a year. The drug makers, Takeda Pharmaceuticals Co., has stated that they have net profit of $1.74 billion for the first part [...]
By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.
Archives
- May 2013
- April 2013
- February 2013
- January 2013
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
Categories
- Actos and bladder cancer lawyers (17)
- Actos attorneys (12)
- Actos bladder cancer attorneys (9)
- Actos bladder cancer lawsuit attorneys (9)
- Actos bladder cancer lawsuit lawyers (16)
- Actos bladder cancer lawyers (25)
- Actos lawsuit attorneys (26)
- Actos lawsuit lawyers (24)
- Actos lawyers (8)
- Actos mass tort attorneys (2)
- Actos side effects lawyers (3)
- Bladder Cancer and Actos (2)
- bladder cancer symptoms lawyers (4)
- bladder cancer treatments (1)
- Diabetes drug side effect (3)
- Risk of diabetes (1)
- Takeda Pharmaceuticals (4)
- Uncategorized (1)
Blogroll
- Accutane Lawsuit Attorney
- Depakote Lawyers
- Depuy Lawsuit Attorney
- Mesothelioma Lawyers
- Reglan Lawsuit Attorney
- Topamax Lawsuit Attorney